Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study

J Rheumatol 2025; doi: 10.3899/jrheum.2025-0658 In the 4th paragraph regarding severe hematological involvement, the criterion for severe leukopenia should be a leukocyte count of < 2 × 10⁹/L. The revised text is "severe leukopenia (leukocyte count < 2 × 10⁹/L)." This correction applies only to the October 1 First Release. The correct text appears in the print and online issues.